KRT6A knockdown rescued the disease-associated downregulation of these molecules in rosacea and psoriasis mouse models (Supplementary Fig. 8E), suggesting that KRT6A may contribute to skin inflammation by modulating barrier function. This evidence concerns the gene KRT6A and dermatitis.